Ireland shire PLC confirms the fourth contact with abbvie

Source: great wisdom astak news agency on July 14, 2014, Irish pharmaceutical company shire PLC released a notice on Friday confirming that the company is in contact with American pharmaceutical company abbvie on the acquisition This is the fourth time the two companies have made contact Abbvie, a Chicago based pharmaceutical company, recently raised its previous offer by 11% to $51 billion to acquire shire PLC, which had rejected the offer three times in a row, saying it seriously undervalued the company's market value The star product of abbvie is Humira, which accounts for nearly 60% of the company's performance The company hopes to further enrich its product line through the acquisition of shire PLC Shire PLC bought another orphan drug company, viropharma, for $4.2 billion last year Shire PLC is a specialty drug company based in Dublin, Ireland In the first quarter of 2014, the company's performance increased by 18% year-on-year to US $1.347 billion The top three products in sales performance are lysine amphetamine (vyvanse) for the treatment of ADHD, aminosalicylic acid / mesalazine for the treatment of ulcerative colitis and elaprase for the treatment of Hunt's syndrome.